XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock
Common stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2020       50,000,000                      
Beginning balance at Dec. 31, 2020 $ 1,651     $ 0   $ 1,860     $ (55)   $ 314     $ (468)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation — restricted shares issued 1         1                  
Common Stock issued (in shares)       1,000,000                      
Common Stock issued 1,520         1,520                  
Common Stock repurchased (in shares)       (1,000,000)                      
Common Stock repurchased (486)               (486)            
Unwind Capped Call 397         646     (249)            
Capped Call (101)         (101)                  
Repurchase of 2028 Notes Conversion Option (1,484)         (1,484)                  
Exercise of Convertible Notes (3)         (3)                  
Net income 83                   83        
Other comprehensive income (loss) (47)                         (47)  
Ending balance (in shares) at Dec. 31, 2021       50,000,000 50,000,000                    
Ending balance at Dec. 31, 2021 1,531 $ (97) $ 1,434 $ 0 $ 0 2,439 $ (131) $ 2,308 (790) $ (790) 397 $ 34 $ 431 (515) $ (515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation — restricted shares issued 0         1     (1)            
Common Stock repurchased (147)               (147)            
Shares granted 7               7            
Net income 482                   482        
Other comprehensive income (loss) $ 51                         51  
Ending balance (in shares) at Dec. 31, 2022 50,257,751     50,000,000 50,000,000                    
Ending balance at Dec. 31, 2022 $ 1,827 $ 1 $ 1,828 $ 0 $ 0 2,309   $ 2,309 (931) $ (931) 913 $ 1 $ 914 (464) $ (464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock-based compensation — restricted shares issued 1         1                  
Common Stock repurchased (356)               (356)            
Capped call settlement 0         412     (412)            
Conversion of 2028 Convertible Notes 437         (952)     1,389            
Net income 987                   987        
Other comprehensive income (loss) $ 174                         174  
Ending balance (in shares) at Dec. 31, 2023 50,697,442     50,000,000                      
Ending balance at Dec. 31, 2023 $ 3,071     $ 0   $ 1,770     $ (310)   $ 1,901     $ (290)